Medical Research Council Laboratory of Molecular Biology, Hills Road, Cambridge CB2 0QH, United Kingdom.
Proc Natl Acad Sci U S A. 2011 May 17;108(20):8228-32. doi: 10.1073/pnas.1100185108. Epub 2011 May 3.
The β(1)-adrenergic receptor (β(1)AR) is a G-protein-coupled receptor whose inactive state structure was determined using a thermostabilized mutant (β(1)AR-M23). However, it was not thought to be in a fully inactivated state because there was no salt bridge between Arg139 and Glu285 linking the cytoplasmic ends of transmembrane helices 3 and 6 (the R(3.50) - D/E(6.30) "ionic lock"). Here we compare eight new structures of β(1)AR-M23, determined from crystallographically independent molecules in four different crystals with three different antagonists bound. These structures are all in the inactive R state and show clear electron density for cytoplasmic loop 3 linking transmembrane helices 5 and 6 that had not been seen previously. Despite significantly different crystal packing interactions, there are only two distinct conformations of the cytoplasmic end of helix 6, bent and straight. In the bent conformation, the Arg139-Glu285 salt bridge is present, as in the crystal structure of dark-state rhodopsin. The straight conformation, observed in previously solved structures of β-receptors, results in the ends of helices 3 and 6 being too far apart for the ionic lock to form. In the bent conformation, the R(3.50)-E(6.30) distance is significantly longer than in rhodopsin, suggesting that the interaction is also weaker, which could explain the high basal activity in β(1)AR compared to rhodopsin. Many mutations that increase the constitutive activity of G-protein-coupled receptors are found in the bent region at the cytoplasmic end of helix 6, supporting the idea that this region plays an important role in receptor activation.
β(1)-肾上腺素能受体(β(1)AR)是一种 G 蛋白偶联受体,其非活性状态结构是使用热稳定突变体(β(1)AR-M23)确定的。然而,由于跨膜螺旋 3 和 6 的细胞质末端之间没有 Arg139 和 Glu285 之间的盐桥(连接跨膜螺旋 3 和 6 的细胞质末端的 R(3.50)-D/E(6.30)“离子锁”),因此人们认为它没有处于完全失活状态。在这里,我们比较了β(1)AR-M23 的八个新结构,这些结构是从四个不同晶体中结晶独立的分子中确定的,其中三个晶体与三种不同的拮抗剂结合。这些结构都处于非活性的 R 状态,并且清楚地显示了以前没有看到的跨膜螺旋 5 和 6 之间的细胞质环 3 的电子密度。尽管晶体堆积相互作用有很大差异,但跨膜螺旋 6 的细胞质末端只有两种不同的构象,弯曲和伸直。在弯曲构象中,存在 Arg139-Glu285 盐桥,如黑暗状态视紫红质的晶体结构。在以前解决的β-受体结构中观察到的直构象导致螺旋 3 和 6 的末端相距太远,无法形成离子锁。在弯曲构象中,R(3.50)-E(6.30)距离明显长于视紫红质,表明相互作用也较弱,这可以解释与视紫红质相比,β(1)AR 的基础活性较高。许多增加 G 蛋白偶联受体组成型活性的突变发生在跨膜螺旋 6 的细胞质末端的弯曲区域,这支持了该区域在受体激活中起重要作用的观点。